Table 4.
Model with clinical/copy number variation (CNV) | Model with clinical/miRNA | Model with clinical/miRNA/CNV | ||||
---|---|---|---|---|---|---|
Recurrence probability scale* | Cutoff=0.501 | Cutoff=0.500 | Cutoff=0.553 | |||
Value | 95% CI | Value | 95% CI | Value | 95% CI | |
Sensitivity | 55% | 0.48, 0.61 | 33% | 0.18, 0.47 | 32% | 0.13, 0.52 |
Specificity | 81% | 0.65, 0.94 | 81% | 0.77, 0.85 | 80% | 0.75, 0.85 |
Positive predictive value | 16% | 0.07, 0.25 | 19% | 0.12, 0.25 | 18% | 0.08, 0.26 |
Negative predictive value | 89% | 0.87, 0.91 | 89% | 0.88, 0.91 | 90% | 0.87, 0.92 |
Accuracy | 74% | 0.72, 0.77 | 75% | 0.73, 0.77 | 74% | 0.72, 0.77 |
Note: *Recurrence probability scale: 1/(exp(-score)+1), where score is the resulting value of the prediction model in logit scale. As detailed in methods, the threshold was selected for specificity around 80% and highest sensitivity and negative predictive value. The goal was to create models that would rule out at least 80 of non-recurrent patients but still capturing most of patients with recurrence.